Efficacy, Safety, PK, PD, and ADA of Eculizumab in Chinese Adults With NMOSD

NCT06724809 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

NMOSD
Neuromyelitis Optica Spectrum Disorders

Interventions

DRUG: eculizumab

Sponsor

Alexion Pharmaceuticals, Inc.

Collaborators

[object Object]